Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02829554 · ClinicalTrials.gov registry record
Differential Influences of Integral and Incidental Emotion on Cancer-related Judgments and Decision Making
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 6,242
- Enrollment target
NCT02829554: Completed study, sponsored by National Cancer Institute (NCI).
NCT02829554 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 6,242 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02829554 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 6,242 participants
- Enrollment target
Study Summary
Background: Researchers are testing new methods for research projects. They want to see how people respond to different types of communication, including videos. They also want to learn how people respond to life events and how they pay attention to computer tasks. They want to learn about how various risks and threats affect the way people make decisions. Objectives: To learn how different stimuli and events affect the way people make decisions. Eligibility: Adults ages 18 and older with a U.S. computer address Design: Participants will be recruited online. Participants will take one of three studies online. Each study will take about a half hour. Participants in Study 1 will watch a short video from a popular movie then answer questions. They will also complete 2 questionnaires. One will be about how likely they think it is that they will experience different risks and threats. The other will be about goals for behavior change. Participants in Study 2 will write in detail about a life event. Then they will answer questions. They will also complete the same 2 questionnaires as Study 1. Participants in Study 3 will pay close attention to words and images on a computer. They will answer questions about attitudes toward different behaviors, products, and experiences. ...
Primary Outcome
Perceived susceptibility to cancer and other threats (self-report)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,242 participants |
| Start Date | 2016-07-08 |
| Est. Completion | 2020-05-15 |
What the finished NCT02829554 record still lists
NCT02829554 is an observational study that tracks outcomes without assigning an intervention. Its 6,242 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02829554 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02829554 about?
NCT02829554 is a clinical study titled "Differential Influences of Integral and Incidental Emotion on Cancer-related Judgments and Decision Making". Background: Researchers are testing new methods for research projects. They want to see how people respond to different types of communication, including videos. They also want to learn how people respond to life events and how they pay attention to computer tasks. They want to learn about how vari...
What is the current status of trial NCT02829554?
This trial is currently completed. The enrollment target is 6,242 participants. The study started on 2016-07-08. Estimated completion is 2020-05-15.
Who is sponsoring clinical trial NCT02829554?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03960099 · 6,250 participants · NA
Pictographs for Preventing Wrong-Patient Errors in NICUs
- NCT05440851 · 6,250 participants · NA
Platform of Randomized Adaptive Clinical Trials in Critical Illness
- NCT06566170 · 6,250 participants
A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
- NCT04884802 · 6,254 participants · NA
The GUARDIAN Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI